Clinical Trials List
2025-05-26 - 2031-01-28
Recruiting6
ICD-10C16.0
Malignant neoplasm of cardia
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 王閔宏 Division of General Internal Medicine
- Wang Yao-Kuang Division of General Internal Medicine
- Jeng-Shiun Du Division of General Internal Medicine
- Li-Tzong Chen Division of General Internal Medicine
- Hui-Ching Wang Division of General Internal Medicine
- Tsung-Jang Yeh Division of General Internal Medicine
- Yi-Hsun Chen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高婉真 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chia Kao Division of General Internal Medicine
- Wen-Chi Chou Division of General Internal Medicine
- 黃文冠 Division of General Internal Medicine
- Chan-Keng Yang Division of General Internal Medicine
- Ming-Mo Hou Division of General Internal Medicine
- Po-Jung Su Division of General Internal Medicine
- 余紹銘 Division of General Internal Medicine
- Hung-Chih Hsu Division of General Internal Medicine
- Wen-Chi Shen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YU-YUN SHAO Division of Hematology & Oncology
- 莊建淮 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 陳柏邑 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 李佳真 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- 陳敬左 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱乃祈 Division of Radiology
- 唐振育 Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chang-Fang Chiu Division of General Internal Medicine
- Chi-Ching Chen Division of General Internal Medicine
- 王秀慈 Division of General Internal Medicine
- 陳珈妤 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
500 participants
